NEW YORK, March 18 (Reuters) – Shares of Gilead Sciences Inc are trading at ultra cheap levels as investors broadly shed biotech holdings and question what the company could do for an encore after…
The post Gilead shares look cheap but investors fret over growth appeared first on NASDAQ.